FeesSafety
Pluang+

Ether's growth driven by stablecoins, tokenized equities, and AI transactions, says Sharplink CEO.

Protocol Fundamentals
03 Nov 2026, 14:55 WIB
Tokenpost
View Source
Neutral
Ether's growth driven by stablecoins, tokenized equities, and AI transactions, says Sharplink CEO.

Sharplink CEO Joseph Chalom highlighted that the future growth of Ether (ETH) relies on the expanding use of Ethereum in stablecoins, tokenized public equities, and transactions between artificial intelligence agents. He emphasized that Ethereum's progress is based on these existing applications gaining wider adoption rather than waiting for a single new breakthrough. This suggests a steady, multi-faceted growth path for Ether as these sectors develop further.

Sharplink CEO Joseph Chalom's comments on Ether's growth provide context for the current cryptocurrency market. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Nov 03, 2026 19:03 WIB: out of 50 priced major cryptocurrencies, 12 rose and 37 fell today. Notable movers include BAL (Balancer) at Rp16.297 with an 11.14% increase and EOS (EOS.IO) at Rp12.649 with an 8.13% rise, while CRV (Curve DAO Token) dropped 5.07% to Rp4.721 with a 60% sell order activity.

More News

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...

Market News
Bullish
18 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
3 hours ago
Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
3 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
3 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App